Showing posts with label high dose. Show all posts
Showing posts with label high dose. Show all posts
Monday, May 31, 2010
Tuesday, April 27, 2010
Candidate gene association studies: successes and failures
Abstract
"Epidemiologic studies of twins indicate that 20-40% of common tumors such as breast, colorectal, and prostate cancers are inherited. However, the effect of high penetrance tumor susceptibility genes such as APC, BRCA1, BRAC2, MSH1, MLH2 and MSH6 only accounts for a small fraction of these cancers. Low to moderate penetrance tumor susceptibility genes likely account for the large remaining proportion of familial cancer risk...."
Friday, April 23, 2010
repost: Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy? - Cancer Network
Ovarian Cancer
Oncology NEWS International. Vol. 19 No. 4
Pages: 1 2
Point / Counterpoint
"Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy?"
add your opinions
high dose
,
low dose
,
Paclitaxel
,
Taxol
Thursday, April 15, 2010
Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy? - Cancer Network
Note: This is a good discussion debating pros/cons (requires registration to view/free) - some excerpts from article:
Point / Counterpoint
add your opinions
high dose
,
low dose
,
schedule
,
short duration
,
Taxol
,
treatments
Subscribe to:
Posts
(
Atom
)